SCHEMBL14021038

SCHEMBL14021038

O=C(Nc1ccccc1)c1ccc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 4/20 0.71
JAK2 O60674 5/20 0.67
JAK3 P52333 1/20 0.67
MAPK8 P45983 3/20 0.62
MAPK10 P53779 1/20 0.62
PDGFRB P09619 3/20 0.61
PDGFRA P16234 3/20 0.61
ABL1 P00519 2/20 0.61
BCR P11274 2/20 0.61
PIK3CG P48736 4/20 0.59
PIK3CA P42336 2/20 0.59
PIK3CB P42338 2/20 0.59
PRKD3 O94806 1/20 0.59
PRKCG P05129 1/20 0.59
PRKCB P05771 1/20 0.59
SRC P12931 1/20 0.59
PRKCA P17252 1/20 0.59
PRKCH P24723 1/20 0.59
PRKCI P41743 1/20 0.59
PRKCE Q02156 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021028 0.95 PIK3CA (0.64) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL4004743 0.93 CAMK2D (0.81) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL14021033 0.91 AURKA (0.62) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL14021027 0.91 CAMK2D (0.67) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL14021029 0.90 CAMK2D (0.71) CAMK2DJAK2PDGFRBPDGFRAABL1
SCHEMBL14021032 0.90 PDGFRA (0.62) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL4905540 0.90 ABL1 (0.62) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL14021031 0.89 CAMK2D (0.61) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL14021025 0.88 PDGFRA (0.58) CAMK2DJAK2JAK3MAPK8MAPK10
SCHEMBL4905733 0.88 PDGFRA (0.77) PDGFRBPDGFRAABL1BCRPRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed